The Potential Impact of Rescheduling Cannabis to Schedule III

rescheduling cannabis

Unlocking Potential Tax Advantages

The cannabis industry has experienced significant growth and transformation in recent years, fueled by changing societal attitudes and an increasing number of jurisdictions legalizing both medical and recreational use. One critical aspect that has long affected cannabis businesses is its classification as a Schedule I substance in the United States. This designation imposes various legal and financial challenges on cannabis companies. This article explores the potential tax benefits that could arise if cannabis were to be rescheduled to Schedule III, shedding light on the implications for the industry.

Current Tax Landscape

The federal illegality of cannabis under Schedule I of the Controlled Substances Act (CSA) has far-reaching consequences for cannabis businesses. The Internal Revenue Code (IRC) Section 280E, a provision initially intended to prevent illegal drug traffickers from claiming business deductions, has been applied to cannabis companies. As a result, these businesses face onerous tax burdens, as they are unable to deduct ordinary business expenses, such as rent, wages, and marketing.

Rescheduling to Schedule III

Moving cannabis from Schedule I to Schedule III would signify a shift in its legal status and could have profound implications for the taxation of cannabis companies. Schedule III substances are considered to have a lower potential for abuse compared to Schedule I substances, and they have recognized medical uses. This change could pave the way for more favorable tax treatment and potentially alleviate some of the financial burdens faced by cannabis businesses.

Tax Deductions and Business Expenses

One of the primary advantages of rescheduling cannabis to Schedule III would be the repotential for cannabis companies to claim deductions for ordinary business expenses. IRC Section 280E specifically targets Schedule I and II substances, and Schedule III substances are not subject to the same restrictions. This change would allow cannabis businesses to reduce their taxable income by deducting expenses that are currently disallowed under the existing tax code.

Increased Competitiveness and Economic Growth

Rescheduling cannabis could also boost the competitiveness and overall growth of the cannabis industry. With the ability to deduct business expenses, companies would have more resources to invest in research and development, expansion, and employee benefits. This, in turn, could lead to increased innovation, job creation, and economic development in regions where the cannabis industry operates.


  1. Controlled Substances Act, 21 U.S.C. § 801 et seq. (1970).
  2. Internal Revenue Code, 26 U.S.C. § 280E (1982).
  3. Title 21 Code of Federal Regulations (CFR) – Part 1308 – Schedules of Controlled Substances.
  4. Harrington, D., The Cannabis Manifesto: A New Paradigm for Wellness. North Atlantic Books, 2015.
  5. Pacula, R. L., Kilmer, B., Wagenaar, A. C., Chaloupka, F. J., & Caulkins, J. P. (2014). Developing Public Health Regulations for Marijuana: Lessons from Alcohol and Tobacco. American Journal of Public Health, 104(6), 1021–1028.


While the potential rescheduling of cannabis to Schedule III is a complex and multifaceted issue, it could have significant positive implications for the taxation of cannabis businesses. The ability to claim deductions for ordinary business expenses would alleviate a major financial burden, fostering growth, innovation, and economic development within the industry. As the conversation around cannabis legalization continues, policymakers and industry stakeholders must carefully consider the potential benefits of rescheduling in order to create a more sustainable and competitive landscape for cannabis companies.

We understand the importance of approaching each work integrally and believe in the power of simple.

Melbourne, Australia
(Sat - Thursday)
(10am - 05 pm)